CIRCULATOME Trademark

Trademark Overview


On Friday, November 3, 2023, a trademark application was filed for CIRCULATOME with the United States Patent and Trademark Office. The USPTO has given the CIRCULATOME trademark a serial number of 98253666. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 17, 2024. This trademark is owned by Pharm Bio, Inc.. The CIRCULATOME trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biomedical research services; Research and development in the field of therapies in the fields of biotechnology, genetic medicine, gene therapy, biologics, small molecules, DNA, RNA, proteins, vectors and payloads; Research and development in the field of profiling of circulating cells and factors connecting distant organ sites in vitro, in vivo, and in silico; Research and development in the field of profiling of circulating cells and factors connecting distant organ sites to identify therapeutic targets, mechanisms of disease, monitor disease progression and resolution, validate therapeutic targets, validate therapeutic safety, validate drug delivery technology; Laboratory research services relating to pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Scientific research and development
circulatome

General Information


Serial Number98253666
Word MarkCIRCULATOME
Filing DateFriday, November 3, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, September 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2024

Trademark Statements


Goods and ServicesBiomedical research services; Research and development in the field of therapies in the fields of biotechnology, genetic medicine, gene therapy, biologics, small molecules, DNA, RNA, proteins, vectors and payloads; Research and development in the field of profiling of circulating cells and factors connecting distant organ sites in vitro, in vivo, and in silico; Research and development in the field of profiling of circulating cells and factors connecting distant organ sites to identify therapeutic targets, mechanisms of disease, monitor disease progression and resolution, validate therapeutic targets, validate therapeutic safety, validate drug delivery technology; Laboratory research services relating to pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Scientific research and development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 3, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePharm Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBozeman, MT 59718

Party NamePharm Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBozeman, MT 59718

Trademark Events


Event DateEvent Description
Friday, November 3, 2023NEW APPLICATION ENTERED
Monday, January 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 13, 2024ASSIGNED TO EXAMINER
Wednesday, July 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 23, 2024PUBLISHED FOR OPPOSITION
Monday, June 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT